Hospital del Mar Research Institute Hospital del Mar Research Institute

News

  • General information

    The Anti-Doping Laboratory of Catalonia collaborates with the Tokyo Olympic Laboratory

    Two professionals from the Laboratory will travel to the Japanese capital to support the anti-doping work that will take place during the Olympic Games, which begin on July 23. The Hospital del Mar Institute for Medical Research (IMIM) will once again be Olympic. Two of the Anti-Doping Laboratory of Catalonia professionals at IMIM will work at the Olympic Games Laboratory in Tokyo, which starts this July 23. Sergi Coll and Lídia Requena will travel to Tokyo to work there until August 10. Sergi Coll specializes in detecting anabolic steroids, and Lídia Requena specializes in detecting hormones (erythropoietin, growth hormone ...) and blood transfusions.

    Més informació "The Anti-Doping Laboratory of Catalonia collaborates with the Tokyo Olympic Laboratory"

  • 22/06/2021 - Press release

    More than 6% of Europeans suffer from depression

    6.4% of the European population suffers from depression, according to a study published in The Lancet Public Health. The work was led by researchers from King's College London, the Hospital del Mar Medical Research Institute (IMIM), the Parc de Recerca Sant Joan de Déu-Institut de Recerca Sant Joan de Déu, the Institute of Biomedicine at the University of León (IBIOMED), and the CIBER on Epidemiology and Public Health (CIBERESP). This figure is higher than that estimated by the World Health Organisation (WHO), which calculated the prevalence of this pathology in the European region at 4.2%. Depression is considered to be one of the leading causes of disability around the world, increasing the risk of premature death, decreasing quality of life and being a heavy burden on health systems. In fact, it is estimated that it may affect more than 300 million people worldwide.

    Més informació "More than 6% of Europeans suffer from depression"

  • 01/06/2021 - General information

    Consol Serra Angel Award for Occupational Medicine 2021

    The Jury of the Àngel Prize for Occupational Medicine 2021 has awarded the Prize convened by the Catalan Association of Occupational Health to Dr. Consol Serra Pujadas, in recognition of her dedication to defending health of working people. Consol Serra is the coordinator of the University Pompeu Fabra (UPF) and Hospital del Mar Medical Research Institute (IMIM) Center for research in Occupational Health, Head of the Occupational Health Service of the PSMar and Head of Studies of the "Mateu Orfila-UPF" Occupational Medicine Teaching Unit. The award ceremony will take place on June 15, during the General Assembly of members of the Catalan Association of Occupational Health

    Més informació "Consol Serra Angel Award for Occupational Medicine 2021"

  • 07/05/2001 - Institutional news

    Camille Lassale obtains one of the 15 postdoctoral scholarships from the La Caixa Foundation

    Researcher Camille Lassale from the IMIM Cardiovascular Epidemiology and Genetics Research Group has obtained one of the 15 "Junior Leader Fellowship - Retaining" grants from the La Caixa Foundation to study the impact of nutrition on epigenetic markers. This call is very competitive; of the 399 applications received, only 15 researches have been awarded throughout Spain and Portugal, and of these 15, there are only four women. The Junior Leader Fellowships postdoctoral research program aims to hire excellent researchers of any nationality who wish to continue their research career in Spain or Portugal. The objectives of this program are to promote innovative and high-quality research in Spain and Portugal and support the best scientific talent by providing them with a competitive and attractive environment in which to conduct excellent research.

    Més informació "Camille Lassale obtains one of the 15 postdoctoral scholarships from the La Caixa Foundation"

  • 03/05/2021 - Institutional news

    Antonio García de Herreros, new member of the Appeals Commission for the Quality Assurance Agency of the Catalan University System

    Dr. Antonio García de Herreros, a researcher at the Hospital del Mar Medical Research Institute (IMIM) and professor in the Department of Experimental and Health Sciences at Pompeu Fabra University, has joined the Appeals Committee for the Quality Agency of the Catalan University System (AQU Catalunya), the main instrument for promoting and assessing quality in Catalan universities.

    Més informació "Antonio García de Herreros, new member of the Appeals Commission for the Quality Assurance Agency of the Catalan University System"

  • 08/04/2021 - Press release

    Model developed for predicting long-term breast cancer risk in women participating in screening programmes

    Doctors and researchers at Hospital del Mar and the Hospital del Mar Medical Research Institute (IMIM) have developed and validated a new risk model for breast cancer screening, based on four variables. This is the first time that it has been possible to predict the risk of developing this pathology in the long term, up to twenty years. The study, which has just been published in the journal PLOS ONE, examined data from almost 122,000 women who received a screening mammogram at the Hospital de la Santa Creu i Sant Pau between 1995 and 2015. This study is a continuation of the population-based breast cancer screening research led by Dr. Xavier Castells, head of the Epidemiology and Evaluation Service at Hospital del Mar.

    Més informació "Model developed for predicting long-term breast cancer risk in women participating in screening programmes"

  • 10/03/2021 - Covid-19

    The MINDCOVID project launches website

    MINDCOVID, a project led by the Research Group on Health Services of the Hospital del Mar Medical Research Institute (IMIM) presents its new website. It is a statewide project, in which more than 20 research groups from 6 autonomous communities collaborate, and its objective is to study the mental health of healthcare workers and other essential groups, as well as in patients with COVID-19 and also in a sample of the Spanish general population. MINDCOVID aims to provide a comprehensive assessment of the impact on mental health of the current outbreak of COVID-19 in Spain, and to be a follow-up project to monitor mental health changes over time in the groups studied. On the project's website you will find all the necessary information about the project, the team of professionals and researchers who collaborate with it, as well as information on the latest publications, questionnaires, reports, documentation on the protocol and the latest news and advances in research being conducted.

    Més informació "The MINDCOVID project launches website"

  • 09/03/2021 - Press release

    The benefits of the Mediterranean diet pass on to the families of patients who follow it

    People living with a patient undergoing an intensive weight loss treatment also benefit from this therapy. This has been demonstrated by a team of researchers from the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) along with doctors from Hospital del Mar and the CIBER on the Physiopathology of Obesity and Nutrition (CIBERObn), in collaboration with IDIAPJGol, the Pere Virgili Health Research Institute (IISPV), IDIBELL, IDIBAPS and the Sant Joan de Reus University Hospital. The study has been published in the journal International Journal of Obesity. The study analysed data from 148 family members of patients included in the weight loss and lifestyle programme PREDIMED-Plus (PREVencióDIetaMEDiterranea Plus) over a two-year period. The researchers analysed whether these people also indirectly benefited from the programme, as they were not enrolled in the study and did not receive any direct treatment.

    Més informació "The benefits of the Mediterranean diet pass on to the families of patients who follow it"

  • 26/02/2021 - Press release

    Not all “good” cholesterol is healthy

    HDL cholesterol (high-density lipoprotein cholesterol) or good cholesterol is associated with a decreased risk of cardiovascular disease as it transports cholesterol deposited in the arteries to the liver to be eliminated. This contrasts with the so-called bad cholesterol, LDL (low-density lipoprotein cholesterol), which causes cholesterol to accumulate in the arteries and increases cardiovascular risk. Although drugs that lower bad cholesterol reduce cardiovascular risk, those that raise good cholesterol have not proven effective in reducing the risk of heart disease. This paradox has called into question the relationship between good cholesterol and cardiovascular risk, and researchers are now studying the characteristics of these HDL or good cholesterol particles. 

    Més informació "Not all “good” cholesterol is healthy"

  • 12/01/2021 - Covid-19

    Almost half of Spanish healthcare professionals are at a high risk of mental disorder as a result of COVID-19

    Almost half of Spain's healthcare professionals have a high risk of suffering a mental disorder after the first wave of the COVID-19 pandemic. In addition, 3.5% are experiencing suicidal thoughts (presence of a death wish and persistent thoughts of wanting to die). This is the conclusion of two studies (MINDCOVID project) that surveyed staff in eighteen hospitals across six autonomous regions of Spain (Andalusia, the Basque Country, Castile and Leon, Catalonia, Madrid and the Community of Valencia), led by researchers from the Hospital del Mar Medical Research Institute (IMIM), the CIBER in Epidemiology and Public Health (CIBERESP), and the CIBER in Mental Health (CIBERSAM), in addition to doctors from the Hospital del Mar. The data has been published by the Revista de Psiquiatría y Salud Mental and the journal Depression & Anxiety.

    Més informació "Almost half of Spanish healthcare professionals are at a high risk of mental disorder as a result of COVID-19"

© Institut Hospital del Mar
d'Investigacions Mèdiques
Legal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact